Study of Therapeutic Effect of Sertraline in Premature Ejaculation

Comprative Study of Therapeutic Effect of Two Medicinal Procedures of Sertraline in Premature Ejaculation

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180401039167N1

Enrollment

120

Registered

2018-06-10

Start date

2018-06-22

Completion date

Unknown

Last updated

2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ejaculation. Premature ejaculation

Interventions

Intervention 1: Intervention group 1: Sertraline will receive 50 mg every 12 hours from Abidi-Tehran Pharmaceutical Company for 8 weeks. Intervention 2: Intervention group 2: Sertraline will receive

Eligibility

Sex/Gender

Male

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Male with Premature Ejaculation Possible at least Once Coitus a Week Age between 20 to 65 years

Exclusion criteria

Exclusion criteria: Norologic Disorder Psycologic Disorder Age Less than 20 and Over 65 Years Urinary and Genital Infection History of Pelvic Surgery

Design outcomes

Primary

Measure	Time frame
Time of Ejaculation ( From Vaginal Entrance to Ejaculation ). Timepoint: The Time of Ejaculation at the Beginning of the Study ( Before the Intervention) and 4 and 8 weeks after the start of Sertraline. Method of measurement: Measure the time in seconds by the stopwatch by the patient's wife.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBijan Rezakhaniha

Artesh University of Medical Sciences

reza.bijan1345@ajaums.ac.ir+98 21 2264 6431

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026